+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product (Drug Therapy, E-Cigarettes, and Nicotine Inhalers), Distribution, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 146 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124530
UP TO OFF until Dec 31st 2022
The United States Smoking Cessation & Nicotine De-Addiction Product Market size was estimated at USD 2,618.45 million in 2021, USD 2,882.28 million in 2022, and is projected to grow at a CAGR 9.69% to reach USD 4,562.44 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
  • Based on Distribution, the market was studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Smoking Cessation & Nicotine De-Addiction Product market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smoking Cessation & Nicotine De-Addiction Product Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Smoking Cessation & Nicotine De-Addiction Product Market, including 22nd Century Group, Inc., Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Imperial Tobacco Company of India Limited, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs Inc., NJOY, Inc., Novartis International AG, Perrigo Company PLC, Pfizer, Inc., Philip Morris International Inc., Revolymer PLC by Itaconix, and Takeda Pharmaceutical Co., Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Smoking Cessation & Nicotine De-Addiction Product Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Smoking Cessation & Nicotine De-Addiction Product Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
4. What is the competitive strategic window for opportunities in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
5. What are the technology trends and regulatory frameworks in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
6. What is the market share of the leading vendors in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
7. What modes and strategic moves are considered suitable for entering the United States Smoking Cessation & Nicotine De-Addiction Product Market?
Frequently Asked Questions about the U.S. Smoking Cessation & Nicotine De-Addiction Product Market

What is the estimated value of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?

The U.S. Smoking Cessation & Nicotine De-Addiction Product Market was estimated to be valued at $2618.45 Million in 2021.

What is the growth rate of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?

The growth rate of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market is 9.6%, with an estimated value of $4562.44 Million by 2027.

What is the forecasted size of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?

The U.S. Smoking Cessation & Nicotine De-Addiction Product Market is estimated to be worth $4562.44 Million by 2027.

Who are the key companies in the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?

Key companies in the U.S. Smoking Cessation & Nicotine De-Addiction Product Market include 22nd Century Group, Inc., Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Imperial Tobacco Company of India Limited, Japan Tobacco Inc. and JUUL Labs Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product
6.1. Introduction
6.2. Drug Therapy
6.2.1. Chantix (Varenicline)
6.2.2. Zyban (Bupropion)
6.3. E-Cigarettes
6.4. Nicotine Inhalers
6.5. Nicotine Replacement Therapies
6.5.1. Nicotine Gums
6.5.2. Nicotine Lozenges
6.5.3. Nicotine Sprays
6.5.4. Nicotine Transdermal Patches
6.6. Nicotine Sublingual Tablets
7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution
7.1. Introduction
7.2. Drug Store
7.3. Hospital Pharmacies
7.4. Online Pharmacies
7.5. Retail Pharmacies
8. California Smoking Cessation & Nicotine De-Addiction Product Market9. Florida Smoking Cessation & Nicotine De-Addiction Product Market10. Illinois Smoking Cessation & Nicotine De-Addiction Product Market11. New York Smoking Cessation & Nicotine De-Addiction Product Market12. Ohio Smoking Cessation & Nicotine De-Addiction Product Market13. Pennsylvania Smoking Cessation & Nicotine De-Addiction Product Market14. Texas Smoking Cessation & Nicotine De-Addiction Product Market
15. Competitive Landscape
15.1. Fpnv Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, by Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. 22Nd Century Group, Inc.
16.2. Axsome Therapeutics, Inc.
16.3. British American Tobacco plc
16.4. Cipla Ltd.
16.5. Dr. Reddy's Laboratories Ltd.
16.6. GlaxoSmithKline plc
16.7. Imperial Tobacco Company of India Limited
16.8. Japan Tobacco Inc.
16.9. Johnson & Johnson
16.10. Juul Labs Inc.
16.11. Njoy, Inc.
16.12. Novartis International Ag
16.13. Perrigo Company plc
16.14. Pfizer, Inc.
16.15. Philip Morris International Inc.
16.16. Revolymer plc by Itaconix
16.17. Takeda Pharmaceutical Co., Ltd.
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET DYNAMICS
FIGURE 8. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 34. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 36. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 52. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 23. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 24. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 25. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 27. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 28. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 30. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 31. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 33. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 34. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 36. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 37. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 39. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 40. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 42. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 44. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 45. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 46. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RANKING
TABLE 47. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 48. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET MERGER & ACQUISITION
TABLE 49. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 50. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 51. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET INVESTMENT & FUNDING
TABLE 52. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 53. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: LICENSE & PRICING

Companies Mentioned

  • 22nd Century Group, Inc.
  • Axsome Therapeutics, Inc.
  • British American Tobacco PLC
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Imperial Tobacco Company of India Limited
  • Japan Tobacco Inc.
  • Johnson & Johnson
  • JUUL Labs Inc.
  • NJOY, Inc.
  • Novartis International AG
  • Perrigo Company PLC
  • Pfizer, Inc.
  • Philip Morris International Inc.
  • Revolymer PLC by Itaconix
  • Takeda Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...